Ra Capital Management, L.p.

Ra Capital Management, L.p. is listed in filings as Director, 10% Owner at Artiva Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 11, 2026, including purchase activity and sale activity. Recent filings connect the profile to Artiva Biotherapeutics, Inc. (ARTV), Wave Life Sciences Ltd. (WVE), Vor Biopharma Inc. (VOR), and Tyra Biosciences, Inc. (TYRA). The current snapshot covers public activity from Nov 19, 2025 to Jun 11, 2026. Reported amounts are shown as $4.3M to $3.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.